bioRxivCancer BiologyPreprint
OCT4 expression regulated apoptosis and cell cycle in myeloma cells
Abstract
PurposeOCT4 gene is specifically expressed in embryonic stem cells and plays a very important role in the proliferation, differentiation, and self-renewal of these cells. The abnormal expression of the OCT4 gene has been observed in most malignancies. Expression of this gene can affect the proliferation and apoptosis of malignant cells by activating various signaling pathways. The proliferation and excessive accumulation of myeloma cells in the bone marrow causes the essential complications of multiple myeloma. Genetic changes and mutations play a role in unscheduled proliferation and diminishing of the apoptosis of the myeloma cells. Material and methodsIn this study, the expression of the OCT4 gene by quantitative PCR and its effects on proliferation, apoptosis, and cell cycle of the myeloma cells by flow cytometry was investigated. ResultsThe results of our study indicated that the myeloma cells express the OCT4 gene; and inhibition of the OCT4 gene by siRNA reduced its expression. The siRNA treated myeloma cells indicated decreased proliferation and increased apoptosis. ConclusionAs with studies in other malignancies, our study also revealed that the OCT4 gene was expressed in the myeloma cells, with evidences of increased proliferation and reduced apoptosis in these cells.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Bone morphogenetic protein 4 gene therapy in mice inhibits myeloma tumor growth, but has a negative impact on bone
M. Westhrin, T. Holien, … T. Standal·bioRxiv·Mar 13, 2019
- Failed reprogramming of transformed cells due to induction of apoptosis and senescence impairs tumor progression in lung cancer
P. Pedrosa, Z. Zang, … M. Collado·bioRxiv·Oct 19, 2023
- Significance of Oct-4 transcription factor as a pivotal therapeutic target for CD44+/24- mammary tumour initiating cells; aiming at the root of the recurrence
U. Sen, S. Shanavas, … B. Bose·bioRxiv·May 21, 2021
- Whole genome CRISPR knockout screen reveals ID3 as a key regulator of myeloma cell survival via TCF3 and c-MYC
Clara Andersson-Rusch, Md. Abu Hanif, … Toril Holien·bioRxiv·Sep 9, 2025
- Caspase-resistant ROCK1 expression prolongs survival of E-mu-Myc B cell lymphoma mice.
Katerina Mardilovich, Gregory D. Naylor, … Michael F. Olson·Disease Models & MechanismsPeer-reviewed·Apr 15, 2024
- Oct4 is a gatekeeper of epithelial identity by regulating cytoskeletal organization in skin keratinocytes
E. Christofidou, M. Tomazou, … K. Strati·bioRxiv·May 5, 2023